Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-24 @ 3:20 PM
NCT ID:
NCT06523192
Brief Summary:
We aim to validate the English (UK) translation of the DrHy-Q, and test its reliability in the UK population. This will facilitate for the subsequent economical evaluation of penicillin allergy delabelling.
This research project is part of an MSc in Allergy undertaken by the principal applicant, Dr Patricia Romero, supervised through Imperial College London.
Target population are patients with a drug allergy diagnosed by an Allergist prospectively at the Drug Allergy Clinic.
Is the English version of the Drug Hypersensitivity Quality of Life Questionnaire suitable to be used in the UK population?
Study:
NCT06523192
Study Brief:
Protocol Section:
NCT06523192